English  |  正體中文  |  简体中文  |  Items with full text/Total items : 43312/67235
Visitors : 2166081      Online Users : 24
RC Version 5.0 © Powered By DSPACE, MIT. Enhanced by NTU/NCHU Library IR team.
National Chung Hsing University Institutional Repository - NCHUIR > 獸醫學院 > 獸醫學院 > 依資料類型分類 > 期刊論文 >  Chromium attenuates hepatic damage in a rat model of chronic cholestasis

Please use this identifier to cite or link to this item: http://nchuir.lib.nchu.edu.tw/handle/309270000/135694

標題: Chromium attenuates hepatic damage in a rat model of chronic cholestasis
作者: Chen, W.Y.;Chen, C.J.;Liao, J.W.;Mao, F.C.
關鍵字: Cholestasis;Chromium;Hepatotoxicity;Oxidative stress;type-2 diabetes-mellitus;duct-ligated rat;lipid-peroxidation;liver;fibrosis;matrix metalloproteinases;carbon-tetrachloride;oxidative;stress;trace quantities;supplementation;glucose
日期: 2009
Issue Date: 2012-12-14 12:05:42 (UTC+8)
關連: Life Sciences, Volume 84, Issue 17-18, Page(s) 606-614.
摘要: Aims: Oxidative stress is involved in cholestasis-induced hepatic damage. Therefore, antioxidant therapy is a recommended therapeutic strategy. Studies have illustrated that chromium can enhance antioxidative capacity leading to a resolution of oxidative stress. The aim of this study was to assess whether chromium has protective effects against cholestasis-related liver damage. Main methods: Cholestasis was produced by bile duct ligation (BDL) in male Sprague-Dawley rats for 3 weeks. Rats were randomly divided into four groups. Control and BDL groups were subjected to sham and BDL operation, respectively, and were supplemented with placebo for 3 weeks. The BDL-post Cr group was supplemented with chromium chloride for 3 weeks after BDL operation. The BDL-pre Cr group was supplemented with chromium chloride for 6 weeks starting from 3 weeks before BDL operation. Key findings: In comparison with the control group, the BDL group showed hepatic damage as evidenced by elevation in serum biochemicals, ductular reaction, and fibrosis. These pathophysiological changes were attenuated in the BDL-Pre Cr and BDL-Post Cr groups. However, there was no significant difference between these two groups. The anti-fibrotic effect of chromium was accompanied by reductions in alpha-smooth muscle actin-positive matrix-producing cells and Smad 2/3 activity critical to the fibrogenic potential of transforming growth factor beta 1 (TGF-beta 1). In addition, chromium effectively attenuated BDL-induced hepatic oxidative stress. Significance: The data indicate that chromium attenuates BIDL-induced cholestatic liver injury, bile duct proliferation, and fibrosis. The hepatoprotective effect of chromium is associated with antioxidative potential. (C) 2009 Elsevier Inc. All rights reserved.
Relation: Life Sciences
Appears in Collections:[依資料類型分類] 期刊論文
[依教師分類] 毛嘉洪
[依教師分類] 廖俊旺

loading Web of Knowledge data....

Files in This Item:

File SizeFormat






聯絡網站維護人員:wyhuang@nchu.edu.tw,04-22840290 # 412。

DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU/NCHU Library IR team Copyright ©   - Feedback